Nosis Bio CEO to speak at Bay Area Biotech Forum on How AI in Changing Pharma R&D

We’re thrilled to announce that Jim Martineau, CEO of Nosis Bio, will be joining an expert panel discussion, How AI is Changing Pharmaceutical R&D, at the upcoming Bay Area Biotech Forum. This forum brings together leading minds in biotech and AI to discuss how artificial intelligence is transforming the landscape of drug discovery and development.

As part of a distinguished panel, Jim will share insights into how Nosis Biosciences leverages AI technologies, including physics-aware deep learning and generative AI, to drive breakthroughs in targeted genetic medicine. By harnessing AI’s potential, Nosis Bio aims to overcome traditional drug development challenges, improving precision and lowering the translational risks associated with clinical trials.

This panel will be an invaluable opportunity for attendees to hear from experts on the cutting-edge applications of AI in biotech. Don’t miss this chance to explore how AI is reshaping the future of pharmaceutical R&D and enhancing patient outcomes.

Visit the CA Life Sciences’s website for more information and to register.

‍